German leptomeningeal disease registry study
Part of Brain & nervous system, Cancer clinical trials.
This study collects information from people with leptomeningeal disease, a condition where cancer spreads to the lining of the brain and spinal cord. By joining, you help researchers learn more about this disease and how it affects people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with leptomeningeal disease, which is cancer that has spread to the lining of the brain or spinal cord.
- You are 18 years old or older.
- You or your legal guardian can give written permission to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches and writes down how patients with cancer that has spread to the brain or spinal cord lining (leptomeningeal metastases) are doing. It helps doctors learn more about this condition without giving any new treatments.
This study is testing different ways to give MRI contrast dye to better see if cancer has spread to the lining of the brain (leptomeningeal disease). It's for people with solid tumors who have had unclear results on standard scans or who are at high risk but have negative tests.
This is a registry (a study that collects health information over time) for adults with suspected or confirmed blood cancers of the myeloid type. It aims to better understand the biology of these illnesses and how different factors affect outcomes, which may improve care in the future.
This study looks at how solid tumors spread to the lining of the brain and spinal cord. It aims to understand this condition better by reviewing patient records.
This study is for people with breast cancer that has spread to the lining of the brain or spinal cord (called leptomeningeal metastasis). Researchers want to understand how to treat this condition and offer care to those who qualify.
This study looks at genetic material from spinal fluid to better understand breast cancer that has spread to the brain or its lining. It may help doctors find new ways to treat this type of cancer.
Hear when a new Leptomeningeal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.